Based on research demonstrating that mechanistically NUT–BRD4 fusion proteins alter chromatin modifications, both bromodomain and extra-terminal motif (BET) [35] and histone deacetylase (HDAC) [36] inhibitors have been tested and shown some efficacy against NMC [37]. Here, NUTM1 is linked to nut midline carcinoma.